The DOI matches its Crossref record.
CD161 (NKR-P1A) Costimulation of CD1d-dependent Activation of Human T Cells Expressing Invariant Vα24JαQ T Cell Receptor α Chains
Open accessAbstract
A population of human T cells expressing an invariant Vα24JαQ T cell antigen receptor (TCR) α chain and high levels of CD161 (NKR-P1A) appears to play an immunoregulatory role through production of both T helper (Th) type 1 and Th2 cytokines. Unlike other CD161+ T cells, the major histocompatibility complex–like nonpolymorphic CD1d molecule is the target for the TCR expressed by these T cells (Vα24invt T cells) and by the homologous murine NK1 (NKR-P1C)+ T cell population. In this report, CD161 was shown to act as a specific costimulatory molecule for TCR-mediated proliferation and cytokine secretion by Vα24invt T cells. However, in contrast to results in the mouse, ligation of CD161 in the absence of TCR stimulation did not result in Vα24invt T cell activation, and costimulation through CD161 did not cause polarization of the cytokine secretion pattern. CD161 monoclonal antibodies specifically inhibited Vα24invt T cell proliferation and cytokine secretion in response to CD1d+ target cells, demonstrating a physiological accessory molecule function for CD161. However, CD1d-restricted target cell lysis by activated Vα24invt T cells, which involved a granule-mediated exocytotic mechanism, was CD161-independent. In further contrast to the mouse, the signaling pathway involved in Vα24invt T cell costimulation through CD161 did not appear to involve stable association with tyrosine kinase p56Lck. These results demonstrate a role for CD161 as a novel costimulatory molecule for TCR-mediated recognition of CD1d by human Vα24invt T cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
Bendelac, A., Savage, P. B., & Teyton, L. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141711 · Cited by 2,155
The Liver as an Immunological Organ
Racanelli, V., & Rehermann, B. (2006) · Hepatology · doi:10.1002/hep.21060 · Cited by 1,377
NKT cells: facts, functions and fallacies
Godfrey, D. I., Hammond, K. J. L., Poulton, L. D., Smyth, M. J., & Baxter, A. G. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01735-7 · Cited by 858
Fuss, I. J., Heller, F., Boirivant, M., Leon, F., Yoshida, M., Fichtner-Feigl, S., Yang, Z., Exley, M., Kitani, A., Blumberg, R. S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19836 · Cited by 797
Self-citationThe unconventional lifestyle of NKT cells
Kronenberg, M., & Gapin, L. (2002) · Nature Reviews Immunology · doi:10.1038/nri854 · Cited by 747
Distinct Functional Lineages of Human Vα24 Natural Killer T Cells
Lee, P. T., Benlagha, K., Teyton, L., & Bendelac, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011908 · Cited by 591
Autoreactivity by design: innate B and T lymphocytes
Bendelac, A., Bonneville, M., & Kearney, J. F. (2001) · Nature Reviews Immunology · doi:10.1038/35105052 · Cited by 416
Loss of IFN-γ Production by Invariant NK T Cells in Advanced Cancer
Muhammad Ali Tahir, S., Cheng, O., Shaulov, A., Koezuka, Y., Bubley, G. J., Wilson, S. B., Balk, S. P., & Exley, M. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.4046 · Cited by 386
Self-citationNieda, M., Okai, M., Tazbirkova, A., Lin, H., Yamaura, A., Ide, K., Abraham, R., Juji, T., Macfarlane, D. J., & Nicol, A. J. (2004) · Blood · doi:10.1182/blood-2003-04-1155 · Cited by 361
Metelitsa, L. S., Naidenko, O. V., Kant, A., Wu, H.-W., Loza, M. J., Perussia, B., Kronenberg, M., & Seeger, R. C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3114 · Cited by 355
CD161 Defines a Transcriptional and Functional Phenotype across Distinct Human T Cell Lineages
Fergusson, J. R., Smith, K. E., Fleming, V. M., Rajoriya, N., Newell, E. W., Simmons, R., Marchi, E., Björkander, S., Kang, Y.-H., Swadling, L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.045 · Cited by 311
Kim, C. H., Johnston, B., & Butcher, E. C. (2002) · Blood · doi:10.1182/blood-2001-12-0196 · Cited by 302
Burdin, N., Brossay, L., & Kronenberg, M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199906)29:06<2014::aid-immu2014>3.0.co;2-g · Cited by 301
Tachibana, T., Onodera, H., Tsuruyama, T., Mori, A., Nagayama, S., Hiai, H., & Imamura, M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0877 · Cited by 295
Cutting Edge: Lectin-Like Transcript-1 Is a Ligand for the Inhibitory Human NKR-P1A Receptor
Rosen, D. B., Bettadapura, J., Alsharifi, M., Mathew, P. A., Warren, H. S., & Lanier, L. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.7796 · Cited by 288
Cutting Edge: Lectin-Like Transcript 1 Is a Ligand for the CD161 Receptor
Aldemir, H., Prod’homme, V., Dumaurier, M.-J., Retiere, C., Poupon, G., Cazareth, J., Bihl, F., & Braud, V. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.7791 · Cited by 285
Jabri, B., De Serre, N. P., Cellier, C., Evans, K., Gache, C., Carvalho, C., Mougenot, J., Allez, M., Jian, R., Desreumaux, P., et al. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70173-9 · Cited by 261
CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines
Pesenacker, A. M., Bending, D., Ursu, S., Wu, Q., Nistala, K., & Wedderburn, L. R. (2013) · Blood · doi:10.1182/blood-2012-08-443473 · Cited by 175
Podbielska, M., Levery, S. B., & Hogan, E. L. (2011) · Clinical Lipidology · doi:10.2217/clp.11.8 · Cited by 21
Metadata
- Authors
- Exley, M., Porcelli, S., Furman, M., Garcia, J., & Balk, S.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1998-09-07
- Volume
- 188
- Issue
- 5
- Pages
- 867-876
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2163466184
- Cited by
- 194
- References
- 0
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.